1. Home
  2. COAG
  3. Earnings

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2026
Q2

Q2 2026 Earnings

8-K

Aug 11, 2026

0001193125-26-343421

Transcript text not available. View on SEC.gov →

2026
Q1

Q1 2026 Earnings

8-K

May 21, 2026

0001193125-26-233375

Transcript text not available. View on SEC.gov →

About Hemab Therapeutics Holdings Inc. Common Stock (COAG) Earnings

This page provides Hemab Therapeutics Holdings Inc. Common Stock (COAG) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.

Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on COAG's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.

Share on Social Networks: